ArticleAccounts of chemical research2026
Chemically Induced Proximity for Targeted Protein O-GlcNAcylation.
Article in Accounts of chemical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
O-GlcNAcylation is a ubiquitous post-translational modification across the mammalian proteome, yet determining how individual O-GlcNAcylation events control specific protein functions remains a central challenge. The O-GlcNAc cycle is governed by two enzymes: O-GlcNAc transferase (OGT), which installs O-GlcNAc, and O-GlcNAcase (OGA), which removes it. Because these enzymes act on thousands of proteins, conventional methods, such as pharmacological inhibition of OGT or OGA, produce broad cellular effects that are difficult to assign to individual substrates. This gap has motivated the development of targeted O-GlcNAcylation strategies, including genetically encoded and chemical biology tools, which have shown that O-GlcNAc can be selectively installed on defined proteins to interrogate protein-specific O-GlcNAc functions. This Account describes the development of O-GlcNAc TArgeting Chimeras, or OGTACs, as chemical tools for targeted O-GlcNAc installation. OGTACs are bifunctional molecules that can recruit OGT to a specific protein of interest. Specifically, an OGTAC consists of an OGT-engaging element, a linker, and a target-recognition motif, which together bring OGT into proximity with a selected substrate. Our studies show that chemically induced proximity can redirect OGT toward selected proteins, thereby creating targeted O-GlcNAc writing that can partially bypass TPR-domain-mediated substrate recognition under engineered recruitment conditions. A central lesson is that productive O-GlcNAc writing requires not only recruitment, but also proper ternary-complex formation and noninhibitory OGT engagement. Moreover, the target-recognition motif determines the targetable protein space and achievable selectivity of the platform. By linking local O-GlcNAc installation to changes in protein turnover, signaling, and transcriptional output, OGTACs provide a conceptual framework for using induced proximity to modulate protein functions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.